Peritoneal metastases from gastric cancer in a nationwide cohort: Incidence, treatment and survival

Anouk Rijken, Marieke Pape, Geert A. Simkens, Ignace H. J. T. de Hingh, Misha D. P. Luyer, Johanna W. van Sandick, Hanneke W. M. van Laarhoven, Rob H. A. Verhoeven, Felice N. van Erning

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

The aims of this study were to investigate incidence, risk factors and treatment of synchronous or metachronous peritoneal metastases (PM) from gastric cancer and to estimate survival of these patients using population-based data. Patients diagnosed with gastric cancer in 2015 to 2016 were selected from the Netherlands Cancer Registry. The incidence of synchronous and metachronous PM were calculated. Multivariable regression analyses were performed to identify factors associated with the occurrence of PM. Treatment and survival were compared between patients with synchronous and metachronous PM. Of 2206 patients with gastric cancer, 741 (34%) were diagnosed with PM. Of these, 498 (23%) had synchronous PM. The cumulative incidence of metachronous PM in patients who underwent potentially curative treatment (n = 675) was 22.8% at 3 years. A factor associated with synchronous and metachronous PM was diffuse type histology. Patients diagnosed with synchronous PM more often received systemic treatment than patients with metachronous PM (35% vs 18%, respectively, P <.001). Median overall survival was comparable between synchronous and metachronous PM (3.2 vs 2.3 months, respectively, P =.731). Approximately one third of all patients with gastric cancer are diagnosed with PM, either at primary diagnosis or during 3-year follow-up after potentially curative treatment. Patients with metachronous PM less often received systemic treatment than those with synchronous PM but survival was comparable between both groups. Future trials are warranted to detect gastric cancer at an earlier stage and to examine strategies that lower the risk of peritoneal dissemination. Also, specific treatment options for patients with gastric PM should be further investigated.

Original languageEnglish
Pages (from-to)992-1002
Number of pages11
JournalInternational journal of cancer
Volume154
Issue number6
Early online date2023
DOIs
Publication statusPublished - 15 Mar 2024

Keywords

  • gastric cancer
  • incidence
  • peritoneal metastases
  • survival
  • treatment

Cite this